TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+5.11%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.64B
AUM Growth
+$64M
(+2.5%)
Cap. Flow
-$37M
Cap. Flow
% of AUM
-1.4%
Top 10 Holdings %
Top 10 Hldgs %
39.72%
Holding
198
New
11
Increased
45
Reduced
37
Closed
18
Top Buys
| 1 |
UnitedHealth
UNH
|
$17.9M |
| 2 |
Stryker
SYK
|
$12.2M |
| 3 |
AstraZeneca
AZN
|
$11.8M |
| 4 |
Danaher
DHR
|
$11.6M |
| 5 |
Pfizer
PFE
|
$11.2M |
Top Sells
| 1 |
Sarepta Therapeutics
SRPT
|
$19M |
| 2 |
SHPG
Shire pic
SHPG
|
$13.4M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$13.2M |
| 4 |
Abbott
ABT
|
$10.5M |
| 5 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$8.69M |
Sector Composition
| 1 | Healthcare | 92.61% |
| 2 | Real Estate | 3% |
| 3 | Financials | 0.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Neurocrine Biosciences
NBIX
$14.3B
| $26.5M | 1.01% |
269,769
-9,650
| -3% | -$948K |
|
27
Teva Pharmaceuticals
TEVA
$21.7B
| $26.4M | 1% |
1,083,843
+620
| +0.1% | +$15.1K |
|
28
Elevance Health
ELV
$70.6B
| $26.3M | 1% |
110,633
+19,151
| +21% | +$4.56M |
|
29
SPDR S&P Biotech ETF
XBI
$5.39B
| $23.8M | 0.9% |
250,460
| – | – |
|
30
CVS Health
CVS
$93.6B
| $23.6M | 0.9% |
366,521
| – | – |
|
|
31
Stryker
SYK
$150B
| $23.1M | 0.88% |
136,631
+72,373
| +113% | +$12.2M |
|
32
Centene
CNC
$14.2B
| $22.8M | 0.86% |
369,638
-90,678
| -20% | -$5.59M |
|
|
SAGE
33
DELISTED
Sage Therapeutics
SAGE
| $22.5M | 0.85% |
143,614
+18,964
| +15% | +$2.97M |
|
34
Novartis
NVS
$251B
| $22.3M | 0.85% |
330,135
-61,603
| -16% | -$4.17M |
|
|
35
Danaher
DHR
$143B
| $19M | 0.72% |
217,558
+133,131
| +158% | +$11.6M |
|
36
Jazz Pharmaceuticals
JAZZ
$7.86B
| $19M | 0.72% |
110,452
-12,030
| -10% | -$2.07M |
|
|
SGEN
37
DELISTED
Seagen Inc. Common Stock
SGEN
| $18.6M | 0.7% |
279,417
-67,082
| -19% | -$4.45M |
|
38
Omega Healthcare
OHI
$12.7B
| $18M | 0.68% |
579,785
| – | – |
|
|
AET
39
DELISTED
Aetna Inc
AET
| $17.8M | 0.68% |
97,122
+49,556
| +104% | +$9.09M |
|
40
Sabra Healthcare REIT
SBRA
$4.56B
| $15.7M | 0.6% |
724,606
| – | – |
|
41
Boston Scientific
BSX
$159B
| $15M | 0.57% |
457,585
| – | – |
|
42
GSK
GSK
$81.5B
| $14.5M | 0.55% |
287,200
-28,599
| -9% | -$1.44M |
|
43
Amicus Therapeutics
FOLD
$2.46B
| $13.7M | 0.52% |
875,304
| – | – |
|
44
Zimmer Biomet
ZBH
$20.9B
| $13.2M | 0.5% |
122,411
+37,869
| +45% | +$4.1M |
|
|
45
BioMarin Pharmaceuticals
BMRN
$11.1B
| $13.2M | 0.5% |
140,538
-140,538
| -50% | -$13.2M |
|
46
McKesson
MCK
$85.5B
| $13.2M | 0.5% |
98,797
| – | – |
|
47
Alnylam Pharmaceuticals
ALNY
$59.2B
| $12.8M | 0.49% |
130,376
| – | – |
|
48
Becton Dickinson
BDX
$55.1B
| $12.7M | 0.48% |
54,302
+36,617
| +207% | +$8.56M |
|
49
Medical Properties Trust
MPW
$2.77B
| $12.1M | 0.46% |
858,586
| – | – |
|
|
WELL.PRI
50
DELISTED
Welltower Inc.
WELL.PRI
| $11.9M | 0.45% |
200,000
| – | – |
|